Health and Human Services Secretary Robert F. Kennedy Jr. is set to reshape vaccine recommendations in the U.S. at an upcoming meeting of his newly appointed panel. Scheduled for next week, this first gathering will focus on two well-established vaccines, highlighting Kennedy’s controversial approach to immunization policies.
- HHS Secretary Robert F. Kennedy Jr. appointed new advisers.
- Panel will discuss thimerosal-containing flu vaccines.
- Recommendations for MMRV vaccine for children under 5.
- Kennedy dismissed all previous panel members.
- Advisory Committee advises CDC on vaccine recommendations.
- Article available exclusively to STAT+ subscribers.
The agenda, released on June 18, 2025, reveals that the panel will discuss recommendations for “thimerosal containing” flu vaccines and revisit the combination measles, mumps, rubella, and varicella vaccine for children under 5. This comes after Kennedy dismissed all previous members, replacing them with individuals known for questioning vaccine safety.
This shift in vaccine advisory leadership raises critical questions about the future of public health in the U.S. Are we prepared for a potential overhaul of vaccine guidelines? The implications could be far-reaching, affecting vaccination rates and public trust in immunization.
- New panel members may influence vaccine safety perceptions.
- Discussion on thimerosal and MMRV vaccine could alter childhood vaccination practices.
- Public health experts are concerned about the impact on vaccination rates.
As this meeting approaches, it’s crucial for the public to stay informed and engaged in discussions about vaccine safety and efficacy. Will these changes foster greater confidence in immunization, or will they sow further doubt?
